Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer. - Yee D; Isaacs C; Wolf DM; Yau C; Haluska P; Giridhar KV; Forero-Torres A; Jo Chien A; Wallace AM; Pusztai L; Albain KS; Ellis ED; et al. (NPJ breast cancer, 2021)